Kentucky is one of the poorest states in the U.S. However, the state has been one of the most successful in reducing its uninsured rate, which happened in part through the Affordable Care Act’s Medicaid expansion that took effect on Jan. 1, 2014. In the past, Kentucky has reported low rates of colorectal cancer screening and has ranked among the highest states for incidence and mortality for the disease.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
